VF
ELOX

Virtu Financial’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Virtu Financial’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-373
Closed -$3K – 2543
2022
Q3 		$3K Buy
+373
New +$4.48K ﹤0.01% 1610
2022
Q2 		– Sell
-513
Closed -$11K – 2330
2022
Q1 		$11K Sell
513
-2,744
-84% -$54K ﹤0.01% 1357
2021
Q4 		$91K Buy
+3,257
New +$142K 0.01% 1170

Other funds holding ELOX

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Virtu Financial's ELOX Position: Q4 2022 in Review

Virtu Financial sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q4 2022, closing a stake of 373 shares — an estimated $3K sold.

Virtu Financial first reported a position in ELOX in Q4 2021 and held it in 3 quarters. The position peaked at $91K in Q4 2021. 19 funds tracked by Wall St. Rank hold ELOX as of Q4 2022.

  • Virtu Financial reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Virtu Financial sold 373 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $3K.
  • Virtu Financial first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Virtu Financial's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $91K in Q4 2021.
  • 19 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Virtu Financial's 13F filing for Q4 2022, filed 15 Feb 2023.